Key Events This Week
May 25: Q4 FY26 profit plunge despite revenue growth
May 27: Intraday low hit amid price pressure and market weakness
May 27: Valuation update signals shift from very expensive to expensive
May 29: Technical indicators point to bearish momentum
May 25: Q4 FY26 Profit Plunge Raises Questions Despite Revenue Growth
Poly Medicure Ltd opened the week under pressure, closing at Rs.1,538.35, down 3.78% from the previous close. This decline followed the release of its Q4 FY26 results, which revealed a significant profit plunge despite reported revenue growth. The earnings disappointment raised concerns about the company’s margin sustainability and operational efficiency, triggering a negative reaction from investors. The stock’s volume of 20,512 shares indicated moderate trading interest amid this news.
Meanwhile, the Sensex surged 1.23% to 35,849.10, highlighting the stock’s divergence from broader market optimism. This disconnect underscored company-specific challenges overshadowing positive market trends.
May 26: Continued Decline Amid Market Stability
The downward momentum intensified on 26 May as Poly Medicure’s shares fell 6.41% to Rs.1,439.80, extending losses amid subdued volume of 18,915 shares. The stock’s decline contrasted with a marginal Sensex dip of 0.17%, reflecting persistent company-specific selling pressure. Investors appeared cautious following the prior day’s profit concerns, with no new positive catalysts emerging to arrest the slide.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
May 27: Intraday Low Amid Price Pressure and Valuation Shift
On 27 May, Poly Medicure’s shares plunged 7.72% to close at Rs.1,328.60, hitting an intraday low of Rs.1,339. This represented a 7% drop from the previous close and marked the lowest price level during the session. The stock’s volatility was elevated, with an intraday volatility of 5.14%, reflecting significant price swings. The decline outpaced the Medical Equipment sector’s 6.03% fall and the Sensex’s modest 0.31% gain, signalling company-specific pressures.
Technically, the stock slipped below all key moving averages, including 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend. The Mojo Score stood at 35.0 with a ‘Sell’ grade, a slight improvement from a prior ‘Strong Sell’ but still indicative of negative sentiment.
Simultaneously, a valuation update downgraded Poly Medicure’s rating from ‘very expensive’ to ‘expensive’. The price-to-earnings ratio moderated to 45.09, while the price-to-book value remained elevated at 4.75. Despite the premium valuation, this shift suggested a subtle improvement in price attractiveness amid the recent price correction. Comparisons with peers showed Poly Medicure’s valuation remained on the higher side but more accessible than before.
May 29: Bearish Momentum Evident in Technical Indicators
The week closed on 29 May with a slight recovery as the stock gained 1.49% to Rs.1,348.40 on lower volume of 13,896 shares. However, technical indicators painted a bearish picture overall. The sharp 7.72% decline two days prior had pushed the stock into a bearish momentum phase, with daily moving averages turning negative and Bollinger Bands signalling downward pressure.
Weekly MACD showed mild bullishness but monthly MACD remained bearish, reflecting short-term attempts at stabilisation amid longer-term weakness. The Relative Strength Index (RSI) indicated neutral momentum, while the Know Sure Thing (KST) oscillator and Dow Theory assessments presented mixed signals across timeframes.
On-Balance Volume (OBV) was mildly bearish weekly but mildly bullish monthly, suggesting some longer-term accumulation despite recent selling. The Mojo Grade remained at ‘Sell’, upgraded from ‘Strong Sell’ earlier in the year, but the overall technical outlook remained cautious.
Poly Medicure Ltd or something better? Our SwitchER feature analyzes this small-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-05-25 | Rs.1,538.35 | -3.78% | 35,849.10 | +1.23% |
| 2026-05-26 | Rs.1,439.80 | -6.41% | 35,787.99 | -0.17% |
| 2026-05-27 | Rs.1,328.60 | -7.72% | 35,899.16 | +0.31% |
| 2026-05-29 | Rs.1,348.40 | +1.49% | 35,417.64 | -1.34% |
Key Takeaways
Profitability Concerns: The week began with a sharp profit decline in Q4 FY26, overshadowing revenue growth and triggering investor caution.
Valuation Adjustment: A shift from ‘very expensive’ to ‘expensive’ valuation grade reflected a modest improvement in price attractiveness amid falling prices, though multiples remain elevated.
Technical Weakness: The stock’s breach of all major moving averages and bearish momentum signals indicate sustained selling pressure and a cautious technical outlook.
Sector and Market Context: Poly Medicure’s underperformance contrasted with a largely stable Sensex, highlighting company-specific challenges within the healthcare services sector.
Conclusion
Poly Medicure Ltd’s week was marked by significant headwinds, with a 15.66% decline reflecting a confluence of disappointing earnings, valuation recalibration, and bearish technical signals. Despite a slight recovery on the final trading day, the stock remains under pressure, trading well below recent highs and key technical levels. The modest upgrade in Mojo Grade from ‘Strong Sell’ to ‘Sell’ suggests some stabilisation, but the overall outlook remains subdued amid sectoral challenges and market volatility. Investors should monitor upcoming earnings updates, sector developments, and technical support levels closely to gauge any potential shifts in momentum.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
